Searchable abstracts of presentations at key conferences in endocrinology

ea0063p200 | Diabetes, Obesity and Metabolism 1 | ECE2019

PCSK9 inhibitors effects after 2 years in real life

Gonzalez Molero Inmaculada , Marin Montserrat Gonzalo , Gamgaram Viyey Kishore Doulatram , Fernandez Jose Abuin , Garcia Ignacio Ruiz , Herrera Maria Jose Vallejo , Fuster Gabriel Olveira

Introduction: Recently, PCSK9 inhibitors have been approved in our country for familial hypercholesterolemia and for patients with cardiovascular diseases. They are still scarce data in real life patients effects.Objective: Analyse the features of first patients treated with PCSK9 inhibitors in a specific unit of familial dyslipidemia and the effect on lipid profile and other clinical variables.Material and methods: Data from patie...

ea0049ep76 | Adrenal cortex (to include Cushing's) | ECE2017

Clinical course of patients with adrenal incidentaloma: retrospective analysis of a single center

Serrano Ana Carolina Ruiz , Colet Ana Megia , Cortes Silvia Naf , Ortega Joan Vendrell , Muela Inmaculada Simon , Fraile Esther Solano , Alevras Theodora Michalopoulou

In the adrenal incidentaloma (AI) it is fundamental to determine functionality and benignity. The aim of this study was to evaluated the clinical, radiological and hormonal evolution of AI and compare the frequency of autonomous cortisol secretion (ACS) between American and European Guidelines.Methods: Retrospective evaluation of patients with AI referred to our service in the last 5 years.Results: 140 patients were included, 50.9%...

ea0049ep88 | Adrenal medulla | ECE2017

Pheochromocytoma in neurofibromatosis type 1

Marengo Agustina Pia , Garcia-Sancho Paula , Guerrero Fernando , Peiro Inmaculada , Santacruz Elisa , Ortiz Andres , Diez Juan Jose , Iglesias Pedro , Villabona Carles

Background: Individuals with neurofibromatosis type-1 (NF1) carry an increased risk of pheochromocytoma (PHEO). Detection strategy is unknown but most experts recommend screening if hypertension develops.Objective: Report the characteristics of PHEO in patients with NF1 (NF1 group) and compare them with non-NF1-associated PHEO (non-NF1 group).Methods: Retrospective cohort study of patients undergoing PHEO resection in two Spanish t...

ea0049ep868 | Clinical case reports - Pituitary/Adrenal | ECE2017

Clinical case report: MEN-1 syndrome with coincident AIP gen mutation and MEN-1 gen deletion

Gonzalez-Molero Inmaculada , Arnes Juan Antonio Garcia , Oriola Josep , Romero Stella Gonzalez , Almaraz Maria Cruz , Maraver Silvia , Olveira Gabriel , Tinahones Francisco

We present the clinical case of a family with an initial diagnosis of AIP syndrome with AIP mutation and a secondary diagnosis of MEN syndrome associated because of a large MEN-1 gen deletion. A male patient 16 years old was evaluated because of delayed growth and pubertal development. He had headaches, nausea and vomits since seven years old. MRI showed: Large pituitary mass of 47.6×22×47.2 mm that erode the floor of the sella, extending into the left prepontine cis...

ea0049ep1392 | Thyroid (non-cancer) | ECE2017

Is post-treatment whole body scan useful in differentiated thyroid cancer after thyroid ablation?

Prior-Sanchez Inmaculada , Rosa Alhambra Exposito Maria , Rebollo Roman Angel , Barrera Martin Ana , Moreno Ortega Estefania , Antonio Vallejo Casas Juan , Angeles Galvez Moreno Maria

Background: The short-term follow-up of patients with differentiated thyroid cancer (DTC) after the initial treatment is based on the measurement of stimulated thyroglobulin (s-Tg) and the use of diagnostic whole body scan (WBS).Objective: To evaluate the clinical utility of WBS performed at 6–12 months after thyroidectomy. Examine the correlation between s-Tg and results of WBS.Methods: We retrospectively evaluated all patien...

ea0041gp46 | Bone & Calcium Homeostasis (1) | ECE2016

Denosumab increases bone mineral density in primary hyperparathyroidism treated with cinacalcet

Munoz Jimenez Concepcion , Manuel Quesada Gomez Jose , Moreno Moreno, Maria Rosa Alhambra Exposito Paloma , Inmaculada Prior Sanchez Maria , Angeles Galvez Moreno Maria

Cinacalcet decreases and normalizes serum calcium levels across a broad severity range of primary hyperparathyroidism (PHPT), slightly reduces parathyroid hormone levels which generally remains elevated, whereas it has no effect on bone mineral density (BMD). Therefore, when administering cinacalcet to a patient with PHPT, concomitant treatment with an anti-catabolic drug should be considered.An open-labeled, prospective trial was conducted in 32 patient...

ea0041gp127 | Neuroendocrinology | ECE2016

Hypothalamic GRK2, via GPR54, modulates puberty onset

Avendano Ma Soledad , Ruiz-Pino Francisco , Vazquez Ma Jesus , Velasco Inmaculada , Heras Violeta , Torres Encarni , Manuel Castellano Juan , Roa Juan , Pinilla Leonor , Tena-Sempere Manuel

The G protein-coupled receptor (GPCR) kinase 2, GRK2, is a ubiquitous serine/threonine protein kinase that is able to phosphorylate and desensitize the active form of several GPCR. Compelling, as yet limited, evidence from in vitro studies have suggested a potential role of GRK2 in mediating desensitization of Gpr54, the canonical receptor for kisspeptins that is abundantly expressed in GnRH neurons. Yet, although kisspeptins have been universally recognized as essent...

ea0041ep474 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Pregnancy diabetes in a patient with phenylketonuria: when the diet is complicated

Gonzalo Marin Montserrat , Jose Sanchez Torralbo Francisco , Gonzalez Molero Inmaculada , Morillas Jimenez Virginia , Abuin Fernandez Jose , Contreras Bolivar Victoria , Olveira Fuster Gabriel , Tinahones Madueno Francisco

Precedents: Thirty-nine year old Woman. Classic phenylketonuria diagnosed for neonatal screening in Germany. Good adherence to the diet from the infancy, with good metabolic control. Not response to test with BH4.Pregnancy in 2007 with good controls of phenylalanine (Phe). Son with congenital cardiopathy.Evolution: In 2013 she planed new pregnancy, departing from very good controls (<4 mg/dl) and ingestion of 22–24 Phe&#14...

ea0041ep557 | Diabetes therapy | ECE2016

Randomized clinical trial to compare the effects of glargine multidosis versus CSII therapy on metabolic and oxidative stress parameters in people with type 1 diabetes

de Adana Navas M Soledad Ruiz , Dominguez-Lopez Marta , Rubio Eleazara , Rodriguez Natalia Colomo , Cardona Isabel , Tapia M Jose , Morillas Virgina , Gonzlez Inmaculada , Rojo Gemma

Aims: There are few data comparing oxidative stress markers in CSII versus MDI/G We compared after randomization CSII (Continuous subcutaneous insulin infusion) vs MDI/G therapy (multiple doses of insulin with glargine) in DM1 people previously optimized at MDI/G being the primary objective assessment of metabolic control and oxidative stress.Assess oxidative stress and metabolic control in patients with type 1 diabetes (T1D) after randomization in CSII ...

ea0041ep601 | Endocrine tumours and neoplasia | ECE2016

Adrenal incidentalomas: functionality study

Rebollo-Roman Angel , Moreno-Moreno Paloma , Prior-Sanchez Maria-Inmaculada , Bahamondes-Opazo Rodrigo , Herrera-Martinez Aura-Dulcinea , Barrera-Martin Ana , Galvez-Moreno Maria-Angeles

Introduction: Due to the widespread use of imaging studies performed in hospitalised patients for other indications, adrenal incidentalomas (AI) are frequent findings in the everyday clinical practice. The objective of this research is to describe the prevalence of hormonally active and malignant AI.Patients and methods: Observational retrospective study of a cohort of patients who consulted in the Endocrinology service between 2005 and 2015 because of a...